Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-14-058087
Filing Date
2014-09-26
Accepted
2014-09-26 16:39:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 v375407_424b5.htm 424B5 1598969
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_xtlbio.jpg GRAPHIC 4807
4 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-14-058087.txt   1607108
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-194338 | Film No.: 141124433
SIC: 2834 Pharmaceutical Preparations